...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What now

Hartland, 

Like I said, at BIO International or shortly thereafter I am hoping for an update. 

BearDownAZ 

Share
New Message
Please login to post a reply